Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
879,156
-
Share change
-
-2,556
-
Total reported value
-
$147,563,653
-
Put/Call ratio
-
55%
-
Price per share
-
$167.84
-
Number of holders
-
96
-
Value change
-
-$38,842
-
Number of buys
-
37
-
Number of sells
-
38
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q3 2018
As of 30 Sep 2018 ISHARES TR - U.S. PHARMA ETF (IHE) had 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 879,156 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, BROWN ADVISORY INC, BANK OF AMERICA CORP /DE/, AMERIPRISE FINANCIAL INC, MURPHY CAPITAL MANAGEMENT INC, ROYAL BANK OF CANADA, CIBC World Markets Inc., WELLS FARGO & COMPANY/MN, ARS Wealth Advisors, LLC, and Karp Capital Management Corp.
This table shows 96 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.